Notice: This company has been marked as potentially delisted and may not be actively trading. Immunovia AB (publ) (IMMVF) News Today Add Compare Share Share Headlines Stock AnalysisShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortiumNovember 7, 2024 | prnewswire.comImmunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conferenceSeptember 16, 2024 | prnewswire.comImmunovia publishes prospectus relating to the rights issueMarch 17, 2023 | prnewswire.comImmunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d testDecember 5, 2022 | finance.yahoo.comCenters for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia's IMMray PanCan-d testNovember 30, 2022 | finance.yahoo.comChief Executive Offier, Philipp Mathieu, buys Immunovia warrantsNovember 16, 2022 | finance.yahoo.comImmunovia announces the financial calendar for financial year 2023November 12, 2022 | finance.yahoo.comImmunovia Publishes Interim Report Jan-Sep 2022November 10, 2022 | finance.yahoo.comImmunovia AB: Invitation to Immunovia's Q3 presentationNovember 5, 2022 | finanznachrichten.deInvitation to Immunovia's Q3 presentationNovember 3, 2022 | finance.yahoo.comNomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)October 20, 2022 | finance.yahoo.comImmunovia announces executive management team changes to accelerate execution of strategic prioritiesOctober 19, 2022 | finance.yahoo.comImmunovia AB: Immunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationOctober 18, 2022 | finanznachrichten.deImmunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationOctober 17, 2022 | finance.yahoo.comAttendo International publ AB (ATTE)September 29, 2022 | investing.comCenters for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia's IMMray PanCan-d testSeptember 26, 2022 | finance.yahoo.comImmunovia publ AB (IMMNOV)September 9, 2022 | investing.comImmunovia AB: Immunovia Publishes Interim Report Jan-June 2022August 25, 2022 | finanznachrichten.deImmunovia Publishes Interim Report Jan-June 2022August 24, 2022 | finance.yahoo.comImmunovia to present at Gilmartin Group's Emerging Growth Company ShowcaseAugust 23, 2022 | finance.yahoo.comInvitation to Immunovia's Q2 presentationAugust 22, 2022 | finance.yahoo.comImmunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d testAugust 11, 2022 | finance.yahoo.comImmunovia: CPT PLA Code for the IMMray™ PanCan-d test approvedJuly 5, 2022 | finance.yahoo.comThe PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phaseJune 30, 2022 | finance.yahoo.comPanFAM-1 Results Partly InconclusiveJune 27, 2022 | finance.yahoo.comInvitation to Immunovia's Presentation of PanFAM-1 ResultsJune 27, 2022 | finance.yahoo.comImmunovia AB appoints Philipp Mathieu as permanent CEOJune 3, 2022 | seekingalpha.comPhilipp Mathieu appointed CEO of Immunovia ABJune 2, 2022 | finance.yahoo.comImmunovia gets permits in Maryland, Pennsylvania for pancreatic cancer testMay 24, 2022 | seekingalpha.comImmunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US statesMay 23, 2022 | finance.yahoo.comImmunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US statesMay 17, 2022 | finance.yahoo.comImmunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access USMay 16, 2022 | finance.yahoo.comImmunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18MApril 29, 2022 | seekingalpha.comImmunovia AB: Immunovia Publishes Interim Report January-March 2022April 28, 2022 | finanznachrichten.deImmunovia Publishes Interim Report January-March 2022April 28, 2022 | finance.yahoo.comInvitation to Immunovia's Q1 presentationApril 21, 2022 | finance.yahoo.comCommuniqué from the Annual General Meeting in Immunovia ABApril 7, 2022 | finance.yahoo.comImmunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US businessMarch 28, 2022 | finance.yahoo.comImmunovia AB: Immunovia publishes the annual report for 2021March 10, 2022 | finanznachrichten.deImmunovia publishes the annual report for 2021March 10, 2022 | finance.yahoo.comImmunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-dMarch 8, 2022 | finance.yahoo.comImmunovia AB: Immunovia further strengthens IP portfolio for its IMMray PanCan-d signatureMarch 7, 2022 | finanznachrichten.deImmunovia further strengthens IP portfolio for its IMMray™ PanCan-d signatureMarch 7, 2022 | finance.yahoo.comNotice to the Annual General Meeting of Immunovia AB (publ)March 4, 2022 | finance.yahoo.comImmunovia Publishes Full Year Report 2021February 17, 2022 | finance.yahoo.comInvitation to Immunovia's Q4 presentationFebruary 4, 2022 | finance.yahoo.comImmunovia postpones Annual General Meeting pending the Temporary Meetings ActFebruary 3, 2022 | finance.yahoo.comIMMVF Real-Time QuotesJanuary 25, 2022 | nasdaq.comImmunovia AB: Immunovia appoints Philipp Mathieu as Acting CEOJanuary 20, 2022 | finanznachrichten.deIMMVF After-Hours QuotesJanuary 16, 2022 | nasdaq.com Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. IMMVF Media Mentions By Week IMMVF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMMVF News Sentiment▼0.000.47▲Average Medical News Sentiment IMMVF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMMVF Articles This Week▼00▲IMMVF Articles Average Week Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMMVF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovia AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMMVF Stock Alerts